English  |  正體中文  |  简体中文  |  Items with full text/Total items : 16973/19260 (88%)
Visitors : 7637839      Online Users : 356
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/28502


    標題: Andrographolide Inhibits Nuclear Factor-kappa B Activation through JNK-Akt-p65 Signaling Cascade in Tumor Necrosis Factor-alpha-Stimulated Vascular Smooth Muscle Cells
    作者: Chen, Yu-Ying
    Hsu, Ming-Jen
    Hsieh, Cheng-Ying
    Lee, Lin-Wen
    Chen, Zhih-Cherng
    Sheu, Joen-Rong
    貢獻者: 藥學系
    關鍵字: PATHWAY
    ATHEROSCLEROSIS
    DISEASE
    PROTEIN
    TNF
    AKT
    PHOSPHORYLATION
    PROLIFERATION
    INFLAMMATION
    SUPPRESSION
    日期: 2014
    上傳時間: 2015-05-06 21:18:35 (UTC+8)
    出版者: Hindawi Publishing Corporation
    摘要: Critical vascular inflammation leads to vascular dysfunction and cardiovascular diseases, including abdominal aortic aneurysms, hypertension, and atherosclerosis. Andrographolide is the most active and critical constituent isolated from the leaves of Andrographis paniculata, a herbal medicine widely used for treating anti-inflammation in Asia. In this study, we investigated the mechanisms of the inhibitory effects of andrographolide in vascular smooth muscle cells (VSMCs) exposed to a proinflammatory stimulus, tumor necrosis factor-alpha (TNF-alpha). Treating TNF-alpha-stimulated VSMCs with andrographolide suppressed the expression of inducible nitric oxide synthase in a concentration-dependent manner. A reduction in TNF-alpha-induced c-Jun N-terminal kinase (JNK), Akt, and p65 phosphorylation was observed in andrographolide-treated VSMCs. However, andrographolide affected neither I kappa B alpha degradation nor p38 mitogen-activated protein kinase or extracellular signal-regulated kinase 1/2 phosphorylation under these conditions. Both treatment with LY294002, a phosphatidylinositol 3-kinase/Akt inhibitor, and treatment with SP600125, a JNK inhibitor, markedly reversed the andrographolide-mediated inhibition of p65 phosphorylation. In addition, LY294002 and SP600125 both diminished Akt phosphorylation, whereas LY294002 had no effects on JNK phosphorylation. These results collectively suggest that therapeutic interventions using andrographolide can benefit the treatment of vascular inflammatory diseases, and andrographolide-mediated inhibition of NF-kappa B activity in TNF-alpha-stimulated VSMCs occurs through the JNK-Akt-p65 signaling cascade, an I kappa B alpha-independent mechanism.
    Appears in Collections:[藥學系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML398View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback